EMvision Medical Devices Ltd. (AU:EMV) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
EMvision Medical Devices Ltd. has announced a change in director Patryk Kania’s interest, with the acquisition of 200,000 unlisted options at an exercise price of $3.15, set to expire on December 31, 2027. This move was approved during the company’s Annual General Meeting, indicating strategic positioning by the director.
For further insights into AU:EMV stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue